Man

Kingdom of the West - An Adventure Set in Old Morocco

Retrieved on: 
Tuesday, July 5, 2022
Islam, Surveillance, COMIT, Al-Qaeda, African, Muslims, Man, Marriage, Friends, Female, Lord, Istiqlal, Woman, Westie (person), ISIS, MacNeil, Solution, Politics, Freedom, Colonialism, Taliban, Coffee, Drug, Nightclub, Private investigator

NEW YORK, July 5, 2022 /PRNewswire/ -- ISIS. Al Qaeda. The Taliban. What spurred the rise of Islamic fundamentalists bent on attacking Western nations? Answer: fierce resentment of Western imperialists who colonized Muslim nations, reduced their people to slaves and stole their nations' wealth for decades.

Key Points: 
  • What spurred the rise of Islamic fundamentalists bent on attacking Western nations?
  • Answer: fierce resentment of Western imperialists who colonized Muslim nations, reduced their people to slaves and stole their nations' wealth for decades.
  • Louis De Granville, leader of the Comit du Maroc, the clandestine business leaders that exploited Morocco.
  • Given the rampant anti-Muslim and anti-indigenous sentiment that persists to this day in throughout Western nations, Kingdom of the Westis highly relevant to the times.

Joe Budd for Congress Announces Endorsements

Retrieved on: 
Tuesday, July 5, 2022
View, Man, Law enforcement, Republican, Policy, Club, Philosophy, Budd, Congress, Make America Great Again, Politics, Socialism, Multimedia, Life insurance

"Greetings South Floridians, I was once honored to be your US Congressional District 22 representative. Now, it is my honor to offer this statement of support to my good friend Joe Budd who is seeking to be the next Florida Congressional district 23 representative. With all that we are facing in our beloved America -- the exorbitant inflation and economic woes, the shift from being energy independent to crushing fuel prices, the drug, human, and sex trafficking crises emanating from an open border, the rising crime scourge due to insidious criminal release policies and defunding of law enforcement, the declining regard of US foreign policy and national security posture -- it is time to have a committed constitutional conservative voice representing the interests of South Florida. I have known Joe Budd for over a decade, he is the right person at this crucial time. The failed philosophy of governance known as progressive socialism has proven once again it does not work. Joe Budd will stand upon principle, not politics, and will do South Floridians proud. He will defend your individual rights, freedoms, and liberties and promote the success of your small businesses and end the advance of this woke ideology that even threatens our most vulnerable, our children. God's blessings to Joe in this endeavor!"

Key Points: 
  • Joe Budd is gaining significant support in his run for Congress in Florida's District 23.
  • Now, it is my honor to offer this statement of support to my good friend Joe Budd who is seeking to be the next Florida Congressional district 23 representative.
  • I have known Joe Budd for over a decade, he is the right person at this crucial time.
  • "I'm proud to endorse my friend, Joe Budd, in the Republican primary for Congressional District 23.

ArriVent Biopharma Announces First Patient Enrolled in Global Phase 1b Trial of Furmonertinib in Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR or HER2 Mutations

Retrieved on: 
Tuesday, July 5, 2022
Review, FDA, Patient, Brain, EGFR, GLOBE, Man, Disease, NSCLC, Lung cancer, Non-small-cell lung carcinoma, Mutation, Pharmacokinetics, Fast Track, HER2, Woman, Food, Therapy, Communication, Plasma protein binding, Dead on arrival, Drug development, Safety, Point mutation, Stage 2, Dose, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Pharmaceutical industry

NEWTOWN SQUARE, Pa., July 05, 2022 (GLOBE NEWSWIRE) -- ArriVent Biopharma, Inc., dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that the first patient has been enrolled in its Phase 1b trial of furmonertinib in patients with advanced or metastatic non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) or HER2 mutations, including exon 20 insertion mutations. Furmonertinib, an oral, irreversible, pan-EGFR mutant selective inhibitor—which has been shown to be highly brain penetrant—was granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) in this indication.

Key Points: 
  • Furmonertinib is approved in China as an anticancer therapy for EGFR T790M NSCLC patients, and more recently, as a first-line treatment for classical EGFR mutant NSCLC patients.
  • Furmonertinib is being developed in China by Allist Pharmaceuticals and in the rest of the world by ArriVent Biopharma.
  • Non-small cell lung cancer (NSCLC) is the predominant subtype of lung cancer, accounting for approximately 85% of all cases.
  • 31% of EGFR activating mutations are termed atypical EGFR mutations of which exon 20 insertion mutations constitute 9% of EGFR activating mutations overall.

lululemon Expands International Footprint, Launching in Spain

Retrieved on: 
Tuesday, July 5, 2022
Fashion, Online Retail, Retail, Sports, Luxury, Other Sports, General Sports, Athlete, Passeig de Gràcia, Barcelona, Acquisition, Yoga, Science, Securities Act of 1933, Securities Exchange Act of 1934, Information, International, Climate change, Recession, Man, Growth, Sale, Company, Terminology, U.S. Securities and Exchange Commission, Private sector, Depression, Compliance, Form, LULU, Woman, Ethics, Hypergymnasia, Privacy, Private Securities Litigation Reform Act, Running, Culture, NASDAQ, Form 10-K, Calle de Serrano, Government, News, Online shopping, MIRROR, EU

With significant runway ahead and the Companys "Power of Three 2 growth plan, which includes a quadrupling of its international revenue from 2021 levels by year-end 2026, lululemon enters Spain as the first new market in Europe since 2019.

Key Points: 
  • With significant runway ahead and the Companys "Power of Three 2 growth plan, which includes a quadrupling of its international revenue from 2021 levels by year-end 2026, lululemon enters Spain as the first new market in Europe since 2019.
  • In September, lululemon will open its first Spanish retail locations in the heart of Madrid and Barcelonas shopping districts, on Calle Serrano and Paseo de Gracia respectively.
  • As a brand which supports wellbeing, lululemon has a strong synergy with the active, balanced lifestyle enjoyed in Spain, said Andr Maestrini, Executive Vice President, International.
  • With significant runway in both new and core markets, lululemon continues to introduce the brand to more guests around the world.

Trane® by Trane Technologies Prepares America’s Service Men and Women for Technical Careers with its Trade Warriors Program

Retrieved on: 
Tuesday, July 5, 2022
Commercial Building & Real Estate, Construction & Property, Veterans, Military, Building Systems, Training, Education, Defense, Residential Building & Real Estate, Student, Life, Transport, DOD, U.S. Department of Defense Strategy for Operating in Cyberspace, Man, Curriculum, Air conditioning, Ventilation, EPA, Woman, Partnership, NATE, HVAC, Veteran, NYSE, Trane, Trane Technologies, Interest, Program, Multimedia, Heating, ventilation, and air conditioning, Medicine

Trane by Trane Technologies (NYSE: TT), a global climate innovator, is growing the skilled labor workforce and supporting Americas dedicated military service members through its Trade Warriors program.

Key Points: 
  • Trane by Trane Technologies (NYSE: TT), a global climate innovator, is growing the skilled labor workforce and supporting Americas dedicated military service members through its Trade Warriors program.
  • View the full release here: https://www.businesswire.com/news/home/20220705005196/en/
    Graduates from Trade Warriors third cohort receive their Trane Certified Technician status.
  • Most importantly, the Trade Warriors program provides rewarding careers to service members who have dutifully served our country and helps them transition into life after the military.
  • The Trade Warriors program began in late 2021 in partnership with Raleigh, North Carolina-based RightTek HVAC Training and the Armys Career Skills Program at Fort Bragg.

BWXT Canada Awarded CA$130 Million Component Manufacturing Contract from Bruce Power

Retrieved on: 
Tuesday, July 5, 2022
Manufacturing, Other Manufacturing, Energy, Nuclear, Other Energy, Patient, CEO, Climate change, Workforce, Feeder, Man, BWX Technologies, Industry, U.S. Securities and Exchange Commission, Sound, Annual report, Woman, Bruce Power, Investment, NYSE, MCR, Local, BWXT, Risk, Radiopharmaceutical, Time, Form 10-K, Component, Electricity, Twitter, News, MPP, Security (finance), Shelf Life Extension Program, Property management, Renewable energy, Oil, Arnprior

BWX Technologies, Inc. (NYSE: BWXT) today announced a contract awarded by Bruce Power valued at approximately CA$130 million in support of Bruce Powers Major Component Replacement (MCR) Project.

Key Points: 
  • BWX Technologies, Inc. (NYSE: BWXT) today announced a contract awarded by Bruce Power valued at approximately CA$130 million in support of Bruce Powers Major Component Replacement (MCR) Project.
  • This 10-year contract will allow us to make investments in our workforce and facility, said John MacQuarrie, President of BWXT Canada.
  • Congratulations to BWXT Canada for securing this long-term contract award from Bruce Power, said MPP for Cambridge, Brian Riddell.
  • BWXT Canada Ltd. (BWXT Canada) has over 60 years of expertise and experience in the design, manufacturing, commissioning and service of nuclear power generation equipment.

BD Issues 2021 ESG Report

Retrieved on: 
Tuesday, July 5, 2022
Zero, Efficiency, Water, Becton, Dickinson and Company headquarters, Annual report, Patient, LinkedIn, BDX, Climate change, Health, ESG, Man, Growth, Female, Industry, Becton, U.S. Securities and Exchange Commission, Disease, Goal, Forward-looking statement, Woman, Social Security Government Pension Offset, Statistics, Therapy, Recommender system, Task force, Center, NYSE, Organization, Male, Social, Pyxis, Culture, Race, Safety, Newsweek, Solution, Small business, Twitter, Diversity, Sterilization, Development, Security (finance), Renewable energy, Pharmaceutical industry, Environment, Company

FRANKLIN LAKES, N.J., July 5, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its Fiscal Year 2021 Environmental, Social and Governance (ESG) Report that details ongoing efforts that impact company health, human health, community health and planet health.

Key Points: 
  • The report includes the first performance measurements and progress made toward the company's 2030+ ESG commitments, which were unveiled in October 2021.
  • Transparency BD published its first Inclusion, Diversity and Equity report and its second Cybersecurity report.
  • The ESG report also includes disclosures that follow the guidelines of the October 2021 report "Implementing the Recommendations of the Task Force on Climate-related Financial Disclosures."
  • BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues.

Poxel Announces the Publication of Two Preclinical Articles on X-Linked Adrenoleukodystrophy for PXL065 and PXL770

Retrieved on: 
Tuesday, July 5, 2022
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Diagnosis, NASH, Patient, ABCD1, HSCT, Gait, Growth, Company, Lists of diseases, Haemophilia, Pioglitazone, Euronext Paris, AMPK, Therapy, AMN, Spinal cord, White matter, Fatty liver disease, Metabolic disorder, TZD, Prevalence, Woman, Chronic inflammatory demyelinating polyneuropathy, Journal of Inherited Metabolic Disease, Experiment, Brain, Journal of Pharmacology and Experimental Therapeutics, Degenerative disease, Phenotype, Man, Peroxisome, Inflammation, Peripheral nervous system, Partnership, Weakness, Adrenoleukodystrophy, POC, Sciatic nerve, Cell, Adenosine, Death, Hematopoietic stem cell transplantation, Journal, Incontinence, VLCFA, Metabolism, Disease, Plasma, ALD, Publication, Risk, Pathology, Pharmaceutical industry, Medical device, Imeglimin, Euronext, Pharmacology

POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announces the publication of two preclinical articles on X-Linked Adrenoleukodystrophy (ALD) for PXL065 and PXL770.

Key Points: 
  • POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announces the publication of two preclinical articles on X-Linked Adrenoleukodystrophy (ALD) for PXL065 and PXL770.
  • An article on PXL065 has been published in The Journal of Inherited Metabolic Disease (JIMD) and is entitled Therapeutic potential of deuterium-stabilized (R)-pioglitazone - PXL065 - for X-linked adrenoleukodystrophy.
  • These publications describe similar beneficial preclinical profiles of PXL770 and PXL065 in models of ALD.
  • Listed on Euronext Paris, Poxel is headquartered in Lyon, France, and has subsidiaries in Boston, MA, and Tokyo, Japan.

Photocure Collaborations at EAU Support the Latest Advancements in Bladder Cancer Technology

Retrieved on: 
Tuesday, July 5, 2022
Diagnosis, Science, Patient, Urinary bladder, Cancer, Photocure, OSE, KARL, Bladder cancer, Congress, Recurrence, NMIBC, POWER, European Association of Urology, Blue Light, Population, American Urological Association, Prevalence, Endoscopy, Solution, Carcinoma in situ, ASA, Oslo Stock Exchange, Technology, Attention, Death, Man, Awareness, PDD, Partnership, General manager, BLC, Cell, EAU, Neoplasm, Cystoscopy, Program, CIS, Perfume, Pharmaceutical industry, Television, Medical imaging, Dietary supplement, Urology, T4, MIBC

OSLO, Norway, July 5, 2022 /PRNewswire/ -- Photocure ASA, The Bladder Cancer Company, announces that its collaborations with capital equipment providers support the most advanced technologies including recent blue light system upgrades. These collaborations were most recently showcased at this year's European Association of Urology (EAU) Congress July 1-4, 2022, in Amsterdam. At this Congress, Photocure's commercial teams focused on making this first opportunity to be present "in person" count in order to support its customers and the Urology society. 

Key Points: 
  • "We are proud to support our business partners in their equipment launches and to co-create bladder cancer awareness initiatives to improve the care of bladder cancer patients."
  • Photocure continues to partner with equipment providers to advance bladder cancer awareness and understanding the science around blue light cystoscopy.
  • Bladder cancer is classified into two types, non-muscle invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC), depending on the depth of invasion in the bladder wall.NMIBC remains in the inner layer of cells lining the bladder.
  • Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients.

Frank Perroni's newly released "Wisdom for Millennials and Others" offers readers a helpful Message and Commentary for each day of the year

Retrieved on: 
Tuesday, July 5, 2022
Perroni, Life, Christianity, Achievement, Adoption, Man, Growth, Virtue, ITunes, Barnes, Apple, Millennials, Woman, Workplace, Amazon (company), Education, Tourism, Entertainment, Book, Noble, Knowledge

MEADVILLE, Pa., July 05, 2022  /PRNewswire-PRWeb/ -- "Wisdom for Millennials and Others: The Journey from Knowledge to Wisdom": a careful selection of motivating messages for readers from all backgrounds. It could serve as a handbook for success in school, and in the workplace.

Key Points: 
  • MEADVILLE, Pa., July 05, 2022 /PRNewswire-PRWeb/ -- "Wisdom for Millennials and Others: The Journey from Knowledge to Wisdom": a careful selection of motivating messages for readers from all backgrounds.
  • "Wisdom for Millennials and Others: The Journey from Knowledge to Wisdom" is the creation of published author Frank Perroni, a loving husband and proud son who resides in New York City.
  • Here are some selected contributions, which can educate, motivate, and inspire readers of all ages from millennials to elders.
  • Published by Christian Faith Publishing, Frank Perroni's new book encourages readers to take time each day of the year and to consider a message intended to promote self-motivation and achievement.